1. Andreasen, P. B., Frøland, A., Skovsted, L., Andersen, S. A., Hauge, M.: Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: The role of genetic factors. Acta med. Scand.193, 561?564 (1973)
2. Avery, G. S.: Drug treatment. Principles and practice of clinical pharmacology and therapeutics. Sydney: ADIS Press 1976
3. Berlin, A., Agurell, S., Borgå, O., Lund, L., Sjöqvist, F.: A micromethod for the determination of diphenylydantoin in plasma and cerebrospinal fluid ? a comparison between a gas chromatographic and a spectrophotometric method. Scand. J. clin. Lab. Invest.29, 281?287 (1972)
4. Burns, J. J., Rose, R. K., Chenkin, T., Goldman, A., Schulert, A., Brodie, B. B.: The physiological disposition of phenylbutazone in man and a method for its estimation in biological material. J. Pharmacol. Exp. Ther.109, 346?357 (1953)
5. Chirigos, M. A., Udenfriend, S.: Fluorometric procedure for determining salicylic acid in biologic tissue. J. Lab. clin. Med.54, 769?772 (1959)